Sandra Ruiz-Quezada , Mónica Vázquez-Del Mercado , Isela Parra-Rojas , Héctor Rangel-Villalobos , Carlos Best-Aguilera , Laura Verónica Sánchez-Orozco , José Francisco Muñoz-Valle
{"title":"墨西哥西部健康人群PAI-1启动子多态性的基因型和等位基因频率与生化和血液学参数的关联","authors":"Sandra Ruiz-Quezada , Mónica Vázquez-Del Mercado , Isela Parra-Rojas , Héctor Rangel-Villalobos , Carlos Best-Aguilera , Laura Verónica Sánchez-Orozco , José Francisco Muñoz-Valle","doi":"10.1016/j.anngen.2003.12.001","DOIUrl":null,"url":null,"abstract":"<div><p>We investigated the genotype and allelic frequency of the –675 bp insertion/deletion polymorphism at the <em>PAI-1</em> gene promoter, in healthy Mexican subjects. It was compared to the lipid profile and hematological parameters, and to other healthy worldwide populations. A Mexican population sample of 110 individuals was studied. Demographic data and clinical characteristics of the subjects were registered. Fasting lipid profile, serum glucose, fibrinogen, hematological parameters and leukocyte genomic DNA isolation from peripheral blood were performed in all the participants. Screening of the <em>PAI-1</em> genotype was done by PCR and restriction analysis. Genotype 4G/4G, 4G/5G, 5G/5G frequency in Mexican healthy subjects was: 14.55%, 39.09%, 46.36%, respectively, whereas the allelic frequency for 5G allele was 65.9%. A significant lesser frequency for 4G allele and related genotypes (4G/4G and 4G/5G) was established in healthy subjects from Mexico, respect to all the compared populations. A particular genotype and allelic frequency of this <em>PAI-1</em> polymorphism was established in Mexico. The clinical parameters were not associated according to each genotype of <em>PAI-1.</em></p></div>","PeriodicalId":100089,"journal":{"name":"Annales de Génétique","volume":"47 2","pages":"Pages 155-162"},"PeriodicalIF":0.0000,"publicationDate":"2004-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anngen.2003.12.001","citationCount":"36","resultStr":"{\"title\":\"Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters\",\"authors\":\"Sandra Ruiz-Quezada , Mónica Vázquez-Del Mercado , Isela Parra-Rojas , Héctor Rangel-Villalobos , Carlos Best-Aguilera , Laura Verónica Sánchez-Orozco , José Francisco Muñoz-Valle\",\"doi\":\"10.1016/j.anngen.2003.12.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>We investigated the genotype and allelic frequency of the –675 bp insertion/deletion polymorphism at the <em>PAI-1</em> gene promoter, in healthy Mexican subjects. It was compared to the lipid profile and hematological parameters, and to other healthy worldwide populations. A Mexican population sample of 110 individuals was studied. Demographic data and clinical characteristics of the subjects were registered. Fasting lipid profile, serum glucose, fibrinogen, hematological parameters and leukocyte genomic DNA isolation from peripheral blood were performed in all the participants. Screening of the <em>PAI-1</em> genotype was done by PCR and restriction analysis. Genotype 4G/4G, 4G/5G, 5G/5G frequency in Mexican healthy subjects was: 14.55%, 39.09%, 46.36%, respectively, whereas the allelic frequency for 5G allele was 65.9%. A significant lesser frequency for 4G allele and related genotypes (4G/4G and 4G/5G) was established in healthy subjects from Mexico, respect to all the compared populations. A particular genotype and allelic frequency of this <em>PAI-1</em> polymorphism was established in Mexico. The clinical parameters were not associated according to each genotype of <em>PAI-1.</em></p></div>\",\"PeriodicalId\":100089,\"journal\":{\"name\":\"Annales de Génétique\",\"volume\":\"47 2\",\"pages\":\"Pages 155-162\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.anngen.2003.12.001\",\"citationCount\":\"36\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales de Génétique\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0003399503000959\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de Génétique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003399503000959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters
We investigated the genotype and allelic frequency of the –675 bp insertion/deletion polymorphism at the PAI-1 gene promoter, in healthy Mexican subjects. It was compared to the lipid profile and hematological parameters, and to other healthy worldwide populations. A Mexican population sample of 110 individuals was studied. Demographic data and clinical characteristics of the subjects were registered. Fasting lipid profile, serum glucose, fibrinogen, hematological parameters and leukocyte genomic DNA isolation from peripheral blood were performed in all the participants. Screening of the PAI-1 genotype was done by PCR and restriction analysis. Genotype 4G/4G, 4G/5G, 5G/5G frequency in Mexican healthy subjects was: 14.55%, 39.09%, 46.36%, respectively, whereas the allelic frequency for 5G allele was 65.9%. A significant lesser frequency for 4G allele and related genotypes (4G/4G and 4G/5G) was established in healthy subjects from Mexico, respect to all the compared populations. A particular genotype and allelic frequency of this PAI-1 polymorphism was established in Mexico. The clinical parameters were not associated according to each genotype of PAI-1.